National Guideline Clearinghouse | Extra-corporeal photopheresis in the management of graft-versus-host disease in patients who have received allogeneic blood or bone marrow transplants: recommendations.
Program in Evidence-based Care ||
Cancer Care Ontario
March 10, 2014
Guideline Title
Extra-corporeal
photopheresis in the management of graft-versus-host disease in
patients who have received allogeneic blood or bone marrow transplants:
recommendations.
photopheresis in the management of graft-versus-host disease in
patients who have received allogeneic blood or bone marrow transplants:
recommendations.
Bibliographic Source(s)
| Bredeson C, Rumble RB, Varela NP, Kuruvilla J, Kouroukis CT, Stem Cell Transplant Steering Committee. Extra-corporeal photopheresis in the management of graft-versus-host disease in patients who have received allogeneic blood or bone marrow transplants: recommendations. Toronto (ON): Cancer Care Ontario (CCO); 2013 Aug 29. 29 p. (Recommendation report; no. SCT-5). [35 references] |
Guideline Status
This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original
Guideline, over time will expand to contain new information emerging
from their reviewing and updating activities.
Please visit the Cancer Care Ontario Web site
for details on any new evidence that has emerged and implications to the guidelines.
The EVIDENCE-BASED SERIES report, initially the full original
Guideline, over time will expand to contain new information emerging
from their reviewing and updating activities.
Please visit the Cancer Care Ontario Web site
for details on any new evidence that has emerged and implications to the guidelines. 
.png)
No hay comentarios:
Publicar un comentario